Business Context and Reporting Period
This Form 8-K is a current report filed by Derycz Scientific, Inc. (not Research Solutions, Inc.) on November 15, 2012. The filing details the results of the company's annual meeting of stockholders held on that date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
At the annual meeting, 9,722,910 shares (56.9%) of the 17,087,281 shares entitled to vote were represented. The following matters were approved:
- Board Election: Five directors (Peter Derycz, Merrill McPeak, Scott Ogilvie, Janice Peterson, and Gregory Suess) were elected with overwhelming support, receiving approximately 9.7 million "For" votes each.
- Accountant Ratification: Shareholders ratified the appointment of Weinberg & Company, P.A. as independent accountants for the fiscal year ending June 30, 2013, with 9,711,190 votes "For."
- Equity Plan Amendment: Shareholders approved an amendment to the 2007 Equity Compensation Plan, increasing the maximum number of issuable shares from 1,500,000 to 3,000,000. This received 9,582,751 "For" votes.
Management Commentary and Unusual Items
On November 16, 2012, the Compensation Committee resolved that options granted under the 2007 Equity Compensation Plan through the end of the fiscal year ending June 30, 2013, shall have a per share exercise price equal to the greater of the fair market value of one share of common stock or $1.15.
Investor Verification Checklist
- Verify the correct registrant name is Derycz Scientific, Inc., not Research Solutions, Inc.
- Confirm the impact of the increased equity pool (3,000,000 shares) on potential future dilution.
- Review the $1.15 minimum exercise price floor for new options and its effect on employee compensation costs.
- Check subsequent filings for the actual financial performance for the fiscal year ending June 30, 2013.